Associated Papers
Niraparib for the Treatment of Metastatic NSCLC in a Patient With BRCA2 Germinal Mutation: A Case Report.
Inno A et al.
Clinical Lung Cancer, 2024
Prevalence of BRCA1/BRCA2 pathogenic variation in Chinese Han population.
Dong H et al.
Journal of Medical Genetics, 2021
The BRCA2 mutation status shapes the immune phenotype of prostate cancer.
Jenzer M et al.
Cancer Immunology, Immunotherapy : Cii, 2019
31549213 (PubMed )
Supplement: 262_2019_2393_MOESM1_ESM.pdf
Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.
Hu X et al.
Cancer Biology & Medicine, 2019
Comprehensive analysis of serum tumor markers and BRCA1/2 germline mutations in Chinese ovarian cancer patients.
Deng H et al.
Molecular Genetics & Genomic Medicine, 2019
Analysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencing.
Li G et al.
Journal of Cancer Research and Clinical Oncology, 2017
Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing.
Ng PS et al.
Clinical Genetics, 2016
Select a paper to view details